CI
ONC

Capital International’s BeOne Medicines Ltd ONC Stock Holding History

Capital International’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22M Buy
77,161
+646
+0.8% +$190K 0.72% 39
2026
Q1 		$22.7M Buy
76,515
+8,793
+13% +$2.85M 0.84% 35
2025
Q4 		$20.6M Buy
67,722
+930
+1% +$304K 0.73% 42
2025
Q3 		$22.8M Buy
66,792
+471
+0.7% +$143K 0.82% 35
2025
Q2 		$16.1M Sell
66,321
-3,171
-5% -$778K 0.62% 50
2025
Q1 		$18.9M Sell
69,492
-6,556
-9% -$1.53M 0.82% 36
2024
Q4 		$14M Buy
76,048
+1,500
+2% +$306K 0.57% 49
2024
Q3 		$16.7M Sell
74,548
-144
-0.2% -$25.9K 0.72% 43
2024
Q2 		$10.7M Sell
74,692
-182
-0.2% -$28.1K 0.49% 66
2024
Q1 		$11.7M Buy
74,874
+9,213
+14% +$1.48M 0.56% 56
2023
Q4 		$11.8M Buy
65,661
+2,080
+3% +$376K 0.61% 55
2023
Q3 		$11.4M Sell
63,581
-397
-0.6% -$78.6K 0.66% 54
2023
Q2 		$11.4M Buy
63,978
+639
+1% +$147K 0.64% 59
2023
Q1 		$13.7M Buy
63,339
+3,514
+6% +$843K 0.82% 38
2022
Q4 		$13.2M Buy
59,825
+4,807
+9% +$882K 0.91% 39
2022
Q3 		$7.42M Buy
55,018
+5,971
+12% +$1.03M 0.52% 63
2022
Q2 		$7.94M Buy
49,047
+665
+1% +$104K 0.6% 56
2022
Q1 		$9.13M Hold
48,382
– – 0.52% 63
2021
Q4 		$13.1M Buy
48,382
+18
+0% +$6.08K 0.67% 40
2021
Q3 		$17.6M Buy
48,364
+1,861
+4% +$608K 0.96% 25
2021
Q2 		$16M Sell
46,503
-969
-2% -$321K 0.88% 29
2021
Q1 		$16.5M Sell
47,472
-4,694
-9% -$1.55M 1% 22
2020
Q4 		$13.5M Sell
52,166
-11,823
-18% -$3.26M 0.79% 32
2020
Q3 		$18.3M Buy
63,989
+13,318
+26% +$3.13M 1.24% 20
2020
Q2 		$9.55M Buy
50,671
+575
+1% +$93.6K 0.89% 31
2020
Q1 		$6.17M Buy
+50,096
New +$7.83M 0.69% 41

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Capital International's ONC Position: Q2 2026 in Review

Capital International increased its BeOne Medicines Ltd (ONC) stake by 0.84% in Q2 2026, buying an estimated $190K and bringing the position to 77,161 shares worth $22M. The position accounts for 0.72% of the portfolio, ranked #39.

Capital International first reported a position in ONC in Q1 2020 and has held it in 26 quarters since. The position peaked at $22.8M in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Capital International held 77,161 shares of BeOne Medicines Ltd worth $22M as of Q2 2026.
  • Capital International bought 646 BeOne Medicines Ltd shares in Q2 2026, an estimated $190K.
  • BeOne Medicines Ltd made up 0.72% of Capital International's portfolio in Q2 2026, its #39 holding.
  • Capital International first reported a position in BeOne Medicines Ltd in Q1 2020 and has held it in 26 quarters since.
  • Capital International's BeOne Medicines Ltd position peaked at $22.8M in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Capital International's 13F filing for Q2 2026, filed 12 Aug 2026.